FI960177L - Moninaisia hoidollisia ominaisuuksia omaavat trisubstituoidut imidatsolit - Google Patents

Moninaisia hoidollisia ominaisuuksia omaavat trisubstituoidut imidatsolit Download PDF

Info

Publication number: FI960177L
Authority: FI; Finland
Prior art keywords: therapeutic properties; diverse therapeutic; trisubstituted imidazoles; trisubstituted; imidazoles
Prior art date: 1993-07-16

Application number

FI960177A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI960177A7 (fi

FI960177A0 (fi

Inventor

Jerry Leroy Adams

Peter William Sheldrake

Timothy Francis Gallagher

Ravi Shanker Garigipati

Paul Elliot Bender

Jeffrey Charles Boehm

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-16

Filing date

1994-07-15

Publication date

1996-01-15

1994-07-15 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

1996-01-15 Publication of FI960177A7 publication Critical patent/FI960177A7/fi

1996-01-15 Publication of FI960177A0 publication Critical patent/FI960177A0/fi

1996-01-15 Publication of FI960177L publication Critical patent/FI960177L/fi

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Hematology (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)

FI960177A 1993-07-16 1994-07-15 Moninaisia hoidollisia ominaisuuksia omaavat trisubstituoidut imidatsolit FI960177L (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9273393A	1993-07-16	1993-07-16
PCT/US1994/007969 WO1995002591A1 (en)	1993-07-16	1994-07-15	Tri-substituted imidazoles having multiple therapeutic properties

Publications (3)

Publication Number	Publication Date
FI960177A7 FI960177A7 (fi)	1996-01-15
FI960177A0 FI960177A0 (fi)	1996-01-15
FI960177L true FI960177L (fi)	1996-01-15

Family

ID=22234840

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI960177A FI960177L (fi)	1993-07-16	1994-07-15	Moninaisia hoidollisia ominaisuuksia omaavat trisubstituoidut imidatsolit

Country Status (31)

Country	Link
EP (5)	EP0708768B1 (da)
JP (4)	JPH09500137A (da)
CN (2)	CN1050126C (da)
AP (1)	AP484A (da)
AT (2)	ATE236896T1 (da)
AU (1)	AU694130C (da)
BR (2)	BR9407079A (da)
CA (1)	CA2167311A1 (da)
CZ (1)	CZ11996A3 (da)
DE (2)	DE69434316T2 (da)
DK (1)	DK0708768T3 (da)
DZ (1)	DZ1798A1 (da)
ES (2)	ES2237650T3 (da)
FI (1)	FI960177L (da)
HK (3)	HK1049659A1 (da)
HU (1)	HUT75313A (da)
IL (2)	IL110296A (da)
MA (1)	MA23270A1 (da)
MY (1)	MY116478A (da)
NO (4)	NO316881B1 (da)
NZ (2)	NZ269457A (da)
PL (4)	PL181694B1 (da)
PT (1)	PT708768E (da)
RU (1)	RU2140918C1 (da)
SG (1)	SG52368A1 (da)
SI (1)	SI0708768T1 (da)
SK (1)	SK282342B6 (da)
TW (1)	TW330934B (da)
UA (1)	UA63875C2 (da)
WO (1)	WO1995002591A1 (da)
ZA (1)	ZA945193B (da)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3857751A (en) *	1971-11-15	1974-12-31	Tufdura Ltd	Composite sheet capable of withstanding impingement by particulate materials
US5916891A (en)	1992-01-13	1999-06-29	Smithkline Beecham Corporation	Pyrimidinyl imidazoles
US5840746A (en) *	1993-06-24	1998-11-24	Merck Frosst Canada, Inc.	Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
US5670527A (en) *	1993-07-16	1997-09-23	Smithkline Beecham Corporation	Pyridyl imidazole compounds and compositions
US5593992A (en) *	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
US5616601A (en) *	1994-07-28	1997-04-01	Gd Searle & Co	1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US6613789B2 (en)	1994-07-28	2003-09-02	G. D. Searle & Co.	Heterocyclo-substituted imidazoles for the treatment of inflammation
PL321292A1 (en) *	1995-01-12	1997-11-24	Smithkline Beecham Corp	Novel xchemical compounds
GB9500580D0 (en) *	1995-01-12	1995-03-01	Merck Sharp & Dohme	Therapeutic agents
JPH11503110A (ja) *	1995-02-17	1999-03-23	スミスクライン・ビーチャム・コーポレイション	Ｉｌ−８受容体拮抗剤
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
IL118544A (en)	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US6369068B1 (en)	1995-06-07	2002-04-09	Smithkline Beecham Corporation	Amino substituted pyrimidine containing compounds
US6083949A (en) *	1995-10-06	2000-07-04	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
US5717100A (en) *	1995-10-06	1998-02-10	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
DE19540027A1 (de) *	1995-10-27	1997-04-30	Gruenenthal Gmbh	Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
ZA9610687B (en)	1995-12-22	1997-09-29	Smithkline Beecham Corp	Novel synthesis.
US6046208A (en) *	1996-01-11	2000-04-04	Smithkline Beecham Corporation	Substituted imidazole compounds
AP9700912A0 (en) *	1996-01-11	1997-01-31	Smithkline Beecham Corp	Novel cycloalkyl substituted imidazoles
ZA97175B (en) *	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.
US5756499A (en) *	1996-01-11	1998-05-26	Smithkline Beecham Corporation	Substituted imidazole compounds
EP0883402A4 (en) *	1996-01-11	1999-08-11	Smithkline Beecham Corp	NEW CYCLOALKYL-SUBSTITUTED IMIDAZOLES
EP1005343A4 (en) *	1996-03-08	2000-06-07	Smithkline Beecham Corp	USE OF CSAIDS AS ANGIOGENESIS INHIBITORS
WO1997035856A1 (en) *	1996-03-25	1997-10-02	Smithkline Beecham Corporation	Novel treatment for cns injuries
AU708883B2 (en) *	1996-06-10	1999-08-12	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
WO1998007425A1 (en)	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
US6147080A (en) *	1996-12-18	2000-11-14	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5945418A (en) *	1996-12-18	1999-08-31	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US6608060B1 (en)	1996-12-18	2003-08-19	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5929076A (en) *	1997-01-10	1999-07-27	Smithkline Beecham Corporation	Cycloalkyl substituted imidazoles
US6187799B1 (en)	1997-05-23	2001-02-13	Onyx Pharmaceuticals	Inhibition of raf kinase activity using aryl ureas
US20020156104A1 (en)	1997-06-13	2002-10-24	Jerry L. Adams	Novel pyrazole and pyrazoline substituted compounds
JP2002505690A (ja)	1997-06-19	2002-02-19	スミスクライン・ビーチャム・コーポレイション	新規なアリールオキシピリミジン置換イミダゾール化合物
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
US6489325B1 (en)	1998-07-01	2002-12-03	Smithkline Beecham Corporation	Substituted imidazole compounds
US6251914B1 (en)	1997-07-02	2001-06-26	Smithkline Beecham Corporation	Cycloalkyl substituted imidazoles
US6562832B1 (en)	1997-07-02	2003-05-13	Smithkline Beecham Corporation	Substituted imidazole compounds
TW517055B (en)	1997-07-02	2003-01-11	Smithkline Beecham Corp	Novel substituted imidazole compounds
US6362193B1 (en)	1997-10-08	2002-03-26	Smithkline Beecham Corporation	Cycloalkenyl substituted compounds
EP1021173A1 (en) *	1997-10-10	2000-07-26	Imperial College Innovations Limited	Use of csaid?tm compounds for the management of uterine contractions
JP3337992B2 (ja) *	1997-11-04	2002-10-28	ファイザー製薬株式会社	５−置換ピコリン酸化合物及びその製造方法
JP2001526230A (ja)	1997-12-19	2001-12-18	スミスクライン・ビーチャム・コーポレイション	ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
US7517880B2 (en)	1997-12-22	2009-04-14	Bayer Pharmaceuticals Corporation	Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en)	1997-12-22	2008-02-12	Bayer Pharmaceuticals Corporation	Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
GB9809869D0 (en) *	1998-05-09	1998-07-08	Medical Res Council	Inhibition of protein kinases
BR9910621A (pt)	1998-05-22	2001-01-30	Smithkline Beecham Corp	Novos compostos de imidazol 2-alquil substituìdos
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
EP1109918B1 (en)	1998-06-24	2006-10-04	University of Dundee	Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof
AU4395399A (en) *	1998-07-02	2000-01-24	Sankyo Company Limited	Five-membered heteroaryl compounds
US6207687B1 (en) *	1998-07-31	2001-03-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
ES2221426T3 (es) *	1998-08-20	2004-12-16	Smithkline Beecham Corporation	Nuevos compuestos de triazol sustituidos.
US6548503B1 (en)	1998-11-04	2003-04-15	Smithkline Beecham Corporation	Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
US6239279B1 (en)	1998-12-16	2001-05-29	Smithkline Beecham Corporation	Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
US7351834B1 (en)	1999-01-13	2008-04-01	Bayer Pharmaceuticals Corporation	ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (en)	1999-01-13	2012-05-09	Bayer HealthCare LLC	w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US8124630B2 (en)	1999-01-13	2012-02-28	Bayer Healthcare Llc	ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US20020065296A1 (en)	1999-01-13	2002-05-30	Bayer Corporation	Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
EP1140840B1 (en)	1999-01-13	2006-03-22	Bayer Pharmaceuticals Corp.	-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7122666B2 (en)	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
JP2003514900A (ja)	1999-11-23	2003-04-22	スミスクライン・ビーチャム・コーポレイション	ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４−ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
US6759410B1 (en)	1999-11-23	2004-07-06	Smithline Beecham Corporation	3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
DE60023025T2 (de)	1999-11-23	2006-07-13	Smithkline Beecham Corp.	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
ES2230171T3 (es)	1999-11-23	2005-05-01	Smithkline Beecham Corporation	Compuestos 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p38 quinasa.
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
US6627647B1 (en) *	2000-03-23	2003-09-30	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents
GB0021726D0 (en) *	2000-09-05	2000-10-18	Astrazeneca Ab	Chemical compounds
US7235576B1 (en)	2001-01-12	2007-06-26	Bayer Pharmaceuticals Corporation	Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ITMI20010206A1 (it) *	2001-02-02	2002-08-02	Dompe Spa	Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US7371763B2 (en)	2001-04-20	2008-05-13	Bayer Pharmaceuticals Corporation	Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
FR2823747B1 (fr) *	2001-04-24	2003-05-23	Oreal	Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires
FR2823751B1 (fr) *	2001-04-24	2003-05-23	Oreal	Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires
WO2002094267A1 (en) *	2001-05-24	2002-11-28	Sankyo Company, Limited	Pharmaceutical composition for prevention or treatment of arthritis
DK1478358T3 (da)	2002-02-11	2013-10-07	Bayer Healthcare Llc	Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
ATE529406T1 (de)	2002-02-11	2011-11-15	Bayer Healthcare Llc	Aryl-harnstoffe als kinase inhibitoren
RU2217196C2 (ru) *	2002-02-28	2003-11-27	Небольсин Владимир Евгеньевич	Способ индукции дифференцировки клеток
EP1482931B1 (en)	2002-03-05	2011-10-19	TransTech Pharma, Inc.	Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
AR039241A1 (es)	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
BR0309200A (pt) *	2002-04-12	2005-02-22	Pfizer	Uso de ligandos receptores ep4 no tratamento de doenças envolvidas com a il-6
ES2350977T3 (es)	2002-11-05	2011-01-28	Glaxo Group Limited	Agentes antibacterianos.
EP1636585B2 (en)	2003-05-20	2012-06-13	Bayer HealthCare LLC	Diaryl ureas with kinase inhibiting activity
PL1663978T3 (pl)	2003-07-23	2008-04-30	Bayer Healthcare Llc	Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
AU2006221699A1 (en) *	2005-03-11	2006-09-14	Pfizer Inc.	Crystal forms of an imidazole derivative
SI1864665T1 (sl) *	2005-03-11	2012-09-28	Zenyaku Kogyo Kk	Imunosupresivno sredstvo, ki obsega heterociklično spojino kot učinkovino
RU2297839C1 (ru) *	2005-10-10	2007-04-27	Всероссийский научно-исследовательский институт пантового оленеводства (ВНИИПО)	Лекарственное средство для лечения актиномикоза
CA2772797C (en)	2009-09-30	2018-09-25	Transtech Pharma, Inc.	Substituted imidazole derivatives
MX2012004997A (es)	2009-10-28	2012-06-12	Pfizer	Derivados de imidazol como inhibidores de la caseina quinasa.
RU2418582C1 (ru) *	2010-04-08	2011-05-20	Аверин Константин Михайлович	1,3-диалкилбензимидазолия галогениды - средства для лечения рассеянного склероза
CN104387301B (zh) *	2014-11-11	2016-05-04	常州大学	一种2-氟-4-甲基苯磺酰甲基异腈的合成方法
WO2016149756A1 (en)	2015-03-23	2016-09-29	The University Of Melbourne	Treatment of respiratory diseases
AU2018262108A1 (en) *	2017-05-03	2019-11-21	The University Of Melbourne	Compounds for the treatment of respiratory diseases
AU2019374731B2 (en)	2018-11-07	2025-08-21	Tianli Biotech Pty Ltd	Compounds and compositions for the treatment of respiratory diseases
CN110531023B (zh) *	2019-10-08	2024-06-14	安徽理工大学	一种薄层色谱分析仪
CN114112812B (zh) *	2021-10-29	2024-05-24	华北电力大学	相变颗粒测试装置、固-液相变机理可视化实验台及方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3707475A (en) *	1970-11-16	1972-12-26	Pfizer	Antiinflammatory imidazoles
US3929807A (en) *	1971-05-10	1975-12-30	Ciba Geigy Corp	2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
DE2242454A1 (de) *	1972-08-29	1974-03-07	Bayer Ag	1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
IL95880A (en) *	1989-10-13	1995-12-31	Pfizer	Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis
EP0563286A4 (en) *	1990-12-13	1995-01-11	Smithkline Beecham Corp	Novel csaids
JPH06504779A (ja) *	1990-12-13	1994-06-02	スミスクライン・ビーチャム・コーポレイション	新規ｃｓａｉｄｓ
IL104369A0 (en) *	1992-01-13	1993-05-13	Smithkline Beecham Corp	Novel compounds and compositions

1994
- 1994-07-12 IL IL11029694A patent/IL110296A/xx not_active IP Right Cessation
- 1994-07-13 DZ DZ940081A patent/DZ1798A1/fr active
- 1994-07-13 AP APAP/P/1994/000654A patent/AP484A/en active
- 1994-07-14 MA MA23584A patent/MA23270A1/fr unknown
- 1994-07-14 MY MYPI94001844A patent/MY116478A/en unknown
- 1994-07-15 PT PT94923503T patent/PT708768E/pt unknown
- 1994-07-15 EP EP94923503A patent/EP0708768B1/en not_active Expired - Lifetime
- 1994-07-15 DE DE69434316T patent/DE69434316T2/de not_active Expired - Fee Related
- 1994-07-15 BR BR9407079A patent/BR9407079A/pt not_active Application Discontinuation
- 1994-07-15 FI FI960177A patent/FI960177L/fi unknown
- 1994-07-15 EP EP02079534A patent/EP1291346B1/en not_active Expired - Lifetime
- 1994-07-15 RU RU96103386/04A patent/RU2140918C1/ru not_active IP Right Cessation
- 1994-07-15 SI SI9430449T patent/SI0708768T1/xx unknown
- 1994-07-15 CN CN94193161A patent/CN1050126C/zh not_active Expired - Fee Related
- 1994-07-15 HU HU9503855A patent/HUT75313A/hu unknown
- 1994-07-15 SK SK47-96A patent/SK282342B6/sk unknown
- 1994-07-15 NZ NZ269457A patent/NZ269457A/en unknown
- 1994-07-15 NZ NZ329994A patent/NZ329994A/xx unknown
- 1994-07-15 CA CA002167311A patent/CA2167311A1/en not_active Abandoned
- 1994-07-15 JP JP7504744A patent/JPH09500137A/ja active Pending
- 1994-07-15 PL PL94332406A patent/PL181694B1/pl unknown
- 1994-07-15 EP EP02076580A patent/EP1227091A3/en not_active Withdrawn
- 1994-07-15 EP EP02076582A patent/EP1227092A3/en not_active Withdrawn
- 1994-07-15 DE DE69432463T patent/DE69432463T2/de not_active Expired - Fee Related
- 1994-07-15 WO PCT/US1994/007969 patent/WO1995002591A1/en not_active Ceased
- 1994-07-15 PL PL94332405A patent/PL181723B1/pl unknown
- 1994-07-15 ZA ZA945193A patent/ZA945193B/xx unknown
- 1994-07-15 DK DK94923503T patent/DK0708768T3/da active
- 1994-07-15 UA UA96010110A patent/UA63875C2/uk unknown
- 1994-07-15 PL PL94332408A patent/PL181721B1/pl unknown
- 1994-07-15 ES ES02079534T patent/ES2237650T3/es not_active Expired - Lifetime
- 1994-07-15 EP EP02076581A patent/EP1229035A1/en not_active Withdrawn
- 1994-07-15 ES ES94923503T patent/ES2197167T3/es not_active Expired - Lifetime
- 1994-07-15 PL PL94312614A patent/PL181705B1/pl unknown
- 1994-07-15 AT AT94923503T patent/ATE236896T1/de not_active IP Right Cessation
- 1994-07-15 AT AT02079534T patent/ATE291576T1/de not_active IP Right Cessation
- 1994-07-15 SG SG1996003561A patent/SG52368A1/en unknown
- 1994-07-15 AU AU73354/94A patent/AU694130C/en not_active Ceased
- 1994-07-15 CZ CZ96119A patent/CZ11996A3/cs unknown
- 1994-10-04 TW TW083109192A patent/TW330934B/zh active
1996
- 1996-01-15 NO NO960173A patent/NO316881B1/no not_active IP Right Cessation
1997
- 1997-05-13 BR BR1100546-7A patent/BR1100546A/pt active IP Right Grant
1998
- 1998-05-04 IL IL12431898A patent/IL124318A0/xx unknown
- 1998-06-17 CN CN98115012A patent/CN1218801A/zh active Pending
- 1998-12-16 HK HK03100350.1A patent/HK1049659A1/en unknown
- 1998-12-16 HK HK03100345.9A patent/HK1049657A1/en unknown
- 1998-12-16 HK HK03100349.5A patent/HK1049658A1/en unknown
2001
- 2001-02-19 NO NO20010838A patent/NO20010838D0/no not_active Application Discontinuation
- 2001-02-19 NO NO20010837A patent/NO20010837D0/no not_active Application Discontinuation
- 2001-02-19 NO NO20010839A patent/NO20010839D0/no not_active Application Discontinuation
2003
- 2003-12-10 JP JP2003412020A patent/JP2004083600A/ja active Pending
- 2003-12-10 JP JP2003412024A patent/JP2004149541A/ja active Pending
- 2003-12-10 JP JP2003412029A patent/JP2004099622A/ja active Pending

Also Published As

Publication number	Publication date
CN1129447A (zh)	1996-08-21
AU705568B2 (en)	1999-05-27
NZ269457A (en)	1998-08-26
PL181694B1 (pl)	2001-09-28
ATE291576T1 (de)	2005-04-15
DE69432463D1 (de)	2003-05-15
SK282342B6 (sk)	2002-01-07
EP1227092A2 (en)	2002-07-31
SK4796A3 (en)	1997-01-08
PL312614A1 (en)	1996-04-29
DZ1798A1 (fr)	2002-02-17
BR9407079A (pt)	1996-08-27
ES2237650T3 (es)	2005-08-01
FI960177A7 (fi)	1996-01-15
DK0708768T3 (da)	2003-08-04
NZ329994A (en)	1999-07-29
WO1995002591A1 (en)	1995-01-26
IL110296A0 (en)	1994-10-21
EP1227092A3 (en)	2002-08-07
HK1049658A1 (en)	2003-05-23
JP2004149541A (ja)	2004-05-27
NO960173L (no)	1996-01-15
NO20010837D0 (no)	2001-02-19
NO960173D0 (no)	1996-01-15
CA2167311A1 (en)	1995-01-26
DE69432463T2 (de)	2004-02-12
EP0708768B1 (en)	2003-04-09
FI960177A0 (fi)	1996-01-15
PT708768E (pt)	2003-08-29
JP2004083600A (ja)	2004-03-18
SG52368A1 (en)	1998-09-28
SI0708768T1 (en)	2003-10-31
AU7185098A (en)	1998-08-27
EP1227091A2 (en)	2002-07-31
CN1050126C (zh)	2000-03-08
AU694130B2 (en)	1998-07-16
CZ11996A3 (en)	1996-10-16
PL181723B1 (pl)	2001-09-28
ES2197167T3 (es)	2004-01-01
HU9503855D0 (en)	1996-02-28
NO10837A (no)	1996-01-15
EP0708768A4 (en)	1996-08-21
MY116478A (en)	2004-02-28
EP1291346A1 (en)	2003-03-12
AU7335494A (en)	1995-02-13
NO10839A (no)	1996-01-15
EP1229035A1 (en)	2002-08-07
AP9400654A0 (en)	1994-07-31
NO20010839D0 (no)	2001-02-19
ATE236896T1 (de)	2003-04-15
RU2140918C1 (ru)	1999-11-10
NO316881B1 (no)	2004-06-14
PL181721B1 (en)	2001-09-28
HK1049657A1 (en)	2003-05-23
AP484A (en)	1996-04-23
HUT75313A (en)	1997-05-28
NO10838A (no)	1996-01-15
IL110296A (en)	1999-12-31
TW330934B (en)	1998-05-01
MA23270A1 (fr)	1995-04-01
EP1291346B1 (en)	2005-03-23
BR1100546A (pt)	2004-08-31
EP0708768A1 (en)	1996-05-01
ZA945193B (en)	1995-04-20
NO20010838D0 (no)	2001-02-19
JPH09500137A (ja)	1997-01-07
DE69434316T2 (de)	2006-03-09
UA63875C2 (en)	2004-02-16
DE69434316D1 (de)	2005-04-28
CN1218801A (zh)	1999-06-09
EP1227091A3 (en)	2002-08-07
JP2004099622A (ja)	2004-04-02
IL124318A0 (en)	1998-12-06
HK1049659A1 (en)	2003-05-23
AU694130C (en)	2002-12-05
PL181705B1 (pl)	2001-09-28
HK1012392A1 (en)	1999-07-30

Publication	Publication Date	Title
FI960177A7 (fi)	1996-01-15	Moninaisia hoidollisia ominaisuuksia omaavat trisubstituoidut imidatso lit
NO2000012I1 (no)	2000-11-28	Celecoxib
NO20022254D0 (no)	2002-05-10	Injeksjonsspröyte
NO985734L (no)	1998-12-08	Br÷nnpakning
DE69424027D1 (de)	2000-05-25	Katheter
DE69409481D1 (de)	1998-05-14	Regler
DK0727133T3 (da)	2003-03-17	Headset-grænsefladeenhed
DE69423046D1 (de)	2000-03-23	Schnellzurückziehbarer katheter
DE69403556D1 (de)	1997-07-10	Mikromanipulator
BR9405926A (pt)	1995-12-26	Artigo compósito
FI954537L (fi)	1995-10-27	4-aryyli-isoindoli analgeetteja
BR9406092A (pt)	1995-12-12	Cateter
FI942792L (fi)	1994-12-15	Lipoksigenaasia inhiboivia imidatsoliyhdisteitä
FI962506L (fi)	1996-06-17	Psoriasiksen hoito
DK120993D0 (da)	1993-10-27	Forbindelsesindretning
KR950013358U (ko)	1995-06-15	안마기
KR950013194U (ko)	1995-06-15	장식대용 회전대
KR950002944U (ko)	1995-02-16	회전구이기
KR940024006U (ko)	1994-11-16	미용용구 세트대
ES1025229Y (es)	1994-06-01	Equilibrador magnetico con efecto terapeutico.
KR940026222U (ko)	1994-12-08	안마기
FI934310A0 (fi)	1993-10-01	Liitosrakenne
KR950006583U (ko)	1995-03-21	질통
KR940005337U (ko)	1994-03-18	복합 노트북
KR940005334U (ko)	1994-03-18	복합 노트북